Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic and clinicopathological significance of survivin in colorectal cancer: a meta-analysis.

PloS one - 1 Jan 2013

Krieg Andreas, Werner Thomas A, Verde Pablo E, Stoecklein Nikolas H, Knoefel Wolfram T

Abstract excerpt

Survivin/BIRC5 is a potentially interesting prognostic marker and therapeutic target in colorectal cancer (CRC). However, the available data on survivin expression in CRC are heterogeneous. Thus, to clarify the prognostic relevance of survivin in patients with CRC and its association with clinicopathological parameters we performed a meta-analysis. We screened PubMed and EMBASE for those studies that investigated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inhibitor of Apoptosis Proteins

Share to Lymphatic Metastasis

Share to Neoplasm Staging

Share to Proportional Hazards Models

Share to Survival Analysis

Share to Survivin

Source

Open in PubMed Open full text

Identifiers

PMID: 23755220
DOI: 10.1371/journal.pone.0065338
PMCID: PMC3670901

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic and clinicopathological significance of survivin in colorectal cancer: a meta-analysis.PMID 23755220Read ↗

Survivin: A molecular biomarker in cancer.Semantic proximity Read ↗

Survivin rs9904341 (G>C) polymorphism contributes to cancer risk: an updated meta-analysis of 26 studies.Semantic proximity Read ↗

Association between survivin gene Polymorphism -31G/C and Risk of Lung and Gastrointestinal cancers : A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic StrategiesSemantic proximity Read ↗

Survivin (BIRC5): Implications in cancer therapySemantic proximity Read ↗

The role of survivin as a new target of diagnosis and treatment in human cancer.Semantic proximity Read ↗

Investigations of survivin: the past, present and futureSemantic proximity Read ↗

A comprehensive review and in silico analysis of the role of survivin (BIRC5) in hepatocellular carcinoma hallmarks: A step toward precisionSemantic proximity Read ↗

STAT3 and the STAT3‑regulated inhibitor of apoptosis protein survivin as potential therapeutic targets in colorectal cancer (Review)Semantic proximity Read ↗

Clinical aspects for survivin: a crucial molecule for targeting drug-resistant cancersSemantic proximity Read ↗

Association of survivin polymorphisms with tumor susceptibility: a meta-analysis.Semantic proximity Read ↗

Survivin study: an update of "what is the next wave"?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.